|Table of Contents|

Effects of NFATc1 on proliferation and apoptosis of breast cancer cells by regulating RhoA/ROCK signaling pathway

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2020 04
Page:
562-568
Research Field:
Publishing date:

Info

Title:
Effects of NFATc1 on proliferation and apoptosis of breast cancer cells by regulating RhoA/ROCK signaling pathway
Author(s):
Liu MengmengWei LiWang YijuanLiu PengLiu XinghuaZhang Ming
Department of Pathology,the Third People's Hospital of Zhengzhou,Henan Zhengzhou 450000,China.
Keywords:
breast cancerNFATc1proliferationapoptosis
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2020.04.009
Abstract:
Objective:To detect the expression of NFATc1 in breast cancer and adjacent tissues,and to explore its effect on the proliferation and apoptosis of breast cancer cells.Methods:Adjacent tissues and tumor cancers from thirty-nine breast cancer patients were collected from our hospital.RT-PCR,immunoblotting and immunohistochemical staining were used to detect the expression of NFATc1 in breast cancer tissues and adjacent tissues.Further,the construction of NFATc1 stable knockout MCF7 and MDA-MB-231 using small interfering RNA (siRNA) cell line.The effect of NFATc1 knockdown on the proliferation of breast cancer cells was detected by CCK-8 kit and clone formation assay.The ratio of Ki67 positive cells in breast cancer cells of control group and NFATc1 knockout group was detected by Ki67 staining.In addition,flow cytometry was used to detect the effect of NFATc1 gene knockdown on apoptosis of breast cancer cells.Finally,the expression of RhoA/ROCK signaling pathway in each group was analyzed by immunoblotting.Results:The mRNA and protein expression of NFATc1 in breast cancer patients was significantly increased (P<0.05).Flow cytometry results showed that NFATc1 siRNA intervention significantly promoted apoptosis in two breast cancer cell lines (P<0.05).In addition,Ki67 staining,CCK-8 assay and colony formation assay showed that the proliferative capacity of the two breast cancer cell lines was significantly decreased after NFATc1 knockout (P<0.05).Western blot results revealed that NFATc1 knockdown significantly inhibited the activation of RhoA/ROCK signaling pathway in cancer cells (P<0.05).Conclusion:Inhibition of NFATc1 can promote the apoptosis of breast cancer cells and inhibit the proliferation of breast cancer cells by inhibiting RhoA/ROCK signaling pathway in breast cancer cells.Therefore,NFATc1 is expected to become a new target for the treatment of breast cancer.

References:

[1]Emens LA.Breast cancer immunotherapy:Facts and hopes[J].Clinical Cancer Research,2018,24(3):3001.
[2]Andersson Y,Frisell J,Sylvan M.Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes[J].Breast Cancer Research & Treatment,2018,171(2):359-369.
[3]Dent R,Trudeau M,Pritchard KI.Triple-negative breast cancer:Clinical features and patterns of recurrence[J].Clinical Cancer Research,2018,13(15 Pt 1):4429-4434.
[4]Brisson L,Gillet L,Antelmi E.NaV1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H+ efflux in caveolin-rich microdomains[J].Oncogene,2018,30(17):2070-2076.
[5]Luctkarflude M,Aiken A,Mccoll MA.What do primary care providers think about implementing breast cancer survivorship care[J]?Current Oncology,2018,25(3):196-205.
[6]Irnaten M,Zhdanov A,Brennan D.Activation of the NFAT-calcium signaling pathway in human lamina cribrosa cells in glaucoma[J].Invest Ophthalmol Vis Sci,2018,59(2):831-842.
[7]Lu WC,Xie H,Tie XX.NFAT-1 hyper-activation by methionine enkephalin (MENK) significantly induces cell apoptosis of rats C6 glioma in vivo,and in vitro[J].International Immunopharmacology,2018(56):1-8.
[8]He RL,Wu ZJ,Liu XR.Calcineurin/NFAT signaling modulates pulmonary artery smooth muscle cell proliferation,migration and apoptosis in monocrotaline-induced pulmonary arterial hypertension rats[J].Cellular Physiology & Biochemistry,2018,49(1):172.
[9]Müller MR,Rao A.NFAT,immunity and cancer:A transcription factor comes of age[J].Nature Reviews Immunology,2010,10(9):645.
[10]Ouyang Z,Guo X,Chen X.Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway[J].Oncotarget,2018,9(2):1868.
[11]Dent R,Trudeau M,Pritchard KI.Triple-negative breast cancer:Clinical features and patterns of recurrence[J].Clinical Cancer Research,2018,13(15 Pt 1):4429-4434.
[12]D' Souza V,Daudt H,Kazanjian A.Survivorship care plans for breast cancer patients:Understanding the quality of the available evidence[J].Current Oncology,2017,24(6):e446.
[13]Duffy MJ,Harbeck N,Nap M.Clinical use of biomarkers in breast cancer:Updated guidelines from the European Group on Tumor Markers (EGTM)[J].European Journal of Cancer,2017,75(1):284-298.
[14]Mulder RL,Kremer LCM,Hudson MM.Recommendations for breast cancer surveillance for female survivors of childhood,adolescent,and young adult cancer given chest radiation:A report from the international late effects of childhood cancer guideline harmonization group[J].Lancet Oncology,2017,18(2):e75.
[15]Basant A,Glotzer M.Spatiotemporal regulation of RhoA during cytokinesis[J].Current Biology,2018,28(9):R570-R580.
[16]Matsukawa T,Morita K,Omizu S.Mechanisms of RhoA inactivation and CDC42 and Rac1 activation during zebrafish optic nerve regeneration[J].Neurochemistry International,2018(112):71-80.
[17]Herbert LM,Resta TC,Jernigan NL.RhoA Increases ASIC1a plasma membrane localization and calcium influx in pulmonary arterial smooth muscle cells following chronic hypoxia[J].Am J Physiol Cell Physiol,2018:00159.
[18]Zhang S,Tang Q,Xu F.RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors[J].Molecular Cancer Research Mcr,2009,7(4):570.
[19]Li X,Liu J,Chen B.A positive feedback loop of Profilin-1 and RhoA/ROCK1 promotes endothelial dysfunction and oxidative stress[J].Oxidative Medicine & Cellular Longevity,2018,23(12):2015.
[20]Liang J,Zeng X,Halifu Y.Blocking RhoA/ROCK inhibits the pathogenesis of pemphigus vulgaris by suppressing oxidative stress and apoptosis through TAK1/NOD2-mediated NF-κB pathway[J].Molecular & Cellular Biochemistry,2017,436(1-2):1-8.
[21]Sun K,Duan X,Cai H.Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells[J].Clinical & Experimental Medicine,2016,16(1):37-47.
[22]Zhang C,Wang HJ,Bao QC.NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction[J].Oncotarget,2016,7(45):73593.
[23]Kim YN,Choe SR,Cho KH.Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis[J].Experimental & Molecular Medicine,2017,49(2):e296.
[24]Liu Q,Wang W,Yang X.MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer[J].Oncology Reports,2016,36(1):189-196.
[25]Xu W,Gu J,Ren Q.NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway[J].Tumor Biology,2016,37(4):4493-4500.
[26]Wang L,Wang Z,Li J.NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2[J].International Journal of Molecular Medicine,2015,35(5):1333-1340.

Memo

Memo:
河南省医学科技攻关计划(编号:170001021)
Last Update: 2020-01-14